Indication: Spinal Muscular Atrophy (SMA)

Use of AVXS-101 for treatment of a patient with Spinal Muscular Atrophy (SMA) Type 1

Sub-indication: Spinal Muscular Atrophy (SMA)

Study Type: Drug Study

Principal Investigator: Arpita Lakhotia, M.D.
Norton Children's Neurology, affiliated with the UofL School of Medicine

Sponsor: Sponsor: AveXis Inc

Search our entire site.